KYORIN Pharmaceutical Co., Ltd.【JP:4569】Balance sheet

Market cap

¥103.3B

P/E ratio

19.1x

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03
Cash and cash equivalents	-	30,652	45,712	43,619	44,117	32,007	31,925	27,445	26,994	19,394	13,886	15,021
Marketable securities, current	-	17,867	5,989	5,007	599	501	993	3,399	500	-	99	1,493
Accounts receivable, net	-	47,007	48,296	46,192	47,862	52,635	47,449	40,446	-	-	-	-
Inventories	-	13,868	14,808	12,901	11,749	12,924	17,913	19,545	19,038	19,074	19,031	22,558
Total current assets	-	129,064	138,483	126,267	122,098	114,904	117,058	114,027	116,376	119,030	119,310	136,134
Property, plant and equipment, net	-	19,374	22,788	22,432	21,901	21,792	22,721	23,896	24,334	25,834	28,950	30,303
Marketable securities, non-current	-	31,008	33,464	40,647	50,715	29,799	25,868	23,645	25,703	22,979	22,106	20,042
Total non-current assets	-	54,318	59,342	66,400	76,251	58,130	54,102	53,099	55,547	57,014	58,369	57,483
Total assets	-	183,383	197,825	192,668	198,350	173,034	171,160	167,126	171,924	176,045	177,679	193,618
Accounts payable	-	11,259	11,792	11,157	10,266	11,441	9,776	6,985	10,896	13,762	14,265	15,517
Short-term debt	-	1,372	1,862	1,321	957	20,932	10,400	10,300	10,300	10,300	10,100	7,400
Long-term debt, current	-	-	-	-	-	-	-	-	-	-	10,200	200
Total current liabilities	-	27,773	28,052	25,033	25,134	41,480	31,328	27,407	32,182	34,983	45,491	35,111
Long-term debt, non-current	-	2,227	3,926	3,630	3,912	2,634	12,514	11,036	10,836	10,636	435	20,235
Total non-current liabilities	-	7,009	12,723	9,797	9,918	8,159	17,121	15,057	15,234	15,600	1,404	22,221
Total liabilities	-	34,782	40,776	34,831	35,053	49,639	48,449	42,464	47,416	50,584	46,896	57,333
Common stock and paid-in capital	-	5,452	5,452	5,452	5,452	5,452	5,452	5,452	5,452	5,452	5,452	5,452
Retained earnings	-	137,577	147,331	150,301	152,542	128,999	130,788	132,557	132,710	134,396	136,774	142,789
Stockholders' equity	137,821	148,600	157,049	157,837	163,297	123,395	122,710	124,661	124,507	125,461	130,783	136,285

Raw aggregated data